TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protara Therapeutics (TARA) had its "buy" rating reaffirmed by TD Cowen.
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update [Yahoo! Finance]
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Protara Therapeutics (TARA) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $27.00 price target on the stock.
Protara Therapeutics Highlights TARA-002 NMIBC Data, FDA Plans for Lymphatic Malformations at Oppenheimer Conf [Yahoo! Finance]
Form 10-K Protara Therapeutics, For: Dec 31
Form 8-K Protara Therapeutics, For: Mar 10
Form 144 Protara Therapeutics, Filed by: 667, L.P.
Form 144 Protara Therapeutics, Filed by: Baker Brothers Life Sciences LP
Form 424B7 Protara Therapeutics,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.